Insider Selling: Arteris, Inc. (NASDAQ:AIP) VP Sells 11,250 Shares of Stock

Arteris, Inc. (NASDAQ:AIP) VP Paul L. Alpern sold 11,250 shares of the stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $7.71, for a total transaction of $86,737.50. Following the completion of the transaction, the vice president now owns 74,563 shares of the company’s stock, valued at approximately $574,880.73. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Arteris Stock Down 6.0 %

NASDAQ:AIP traded down $0.45 on Monday, hitting $7.03. 283,885 shares of the company’s stock traded hands, compared to its average volume of 190,467. The firm has a 50-day moving average price of $7.98 and a 200-day moving average price of $7.38. The company has a current ratio of 1.24, a quick ratio of 1.24 and a debt-to-equity ratio of 0.11. The company has a market cap of $270.51 million, a PE ratio of -7.02 and a beta of 1.12. Arteris, Inc. has a 1 year low of $4.20 and a 1 year high of $9.54.

Arteris (NASDAQ:AIP) last released its quarterly earnings results on Thursday, August 1st. The company reported ($0.21) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.07). The business had revenue of $14.58 million for the quarter, compared to the consensus estimate of $13.68 million. Arteris had a negative net margin of 68.37% and a negative return on equity of 229.27%. During the same quarter in the prior year, the business posted ($0.25) EPS. Equities analysts anticipate that Arteris, Inc. will post -0.91 EPS for the current fiscal year.

Analyst Ratings Changes

AIP has been the topic of several analyst reports. Westpark Capital reaffirmed a “buy” rating and set a $11.00 price target on shares of Arteris in a research note on Wednesday, July 31st. Rosenblatt Securities restated a “buy” rating and issued a $15.00 price target on shares of Arteris in a research note on Monday. Finally, Jefferies Financial Group reiterated a “hold” rating and set a $9.00 price objective (down from $11.00) on shares of Arteris in a research note on Monday, May 13th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, Arteris has an average rating of “Moderate Buy” and a consensus target price of $13.00.

Institutional Investors Weigh In On Arteris

A number of hedge funds have recently bought and sold shares of the company. Acuitas Investments LLC boosted its stake in Arteris by 150.3% during the 4th quarter. Acuitas Investments LLC now owns 215,991 shares of the company’s stock valued at $1,272,000 after purchasing an additional 129,692 shares during the period. Victory Capital Management Inc. acquired a new position in shares of Arteris during the fourth quarter valued at about $60,000. Roubaix Capital LLC lifted its stake in shares of Arteris by 34.5% in the fourth quarter. Roubaix Capital LLC now owns 342,664 shares of the company’s stock valued at $2,018,000 after buying an additional 87,920 shares during the period. Worth Venture Partners LLC grew its position in Arteris by 114.3% during the fourth quarter. Worth Venture Partners LLC now owns 109,921 shares of the company’s stock worth $647,000 after buying an additional 58,620 shares in the last quarter. Finally, GSA Capital Partners LLP increased its stake in Arteris by 26.9% during the first quarter. GSA Capital Partners LLP now owns 132,952 shares of the company’s stock valued at $973,000 after acquiring an additional 28,165 shares during the period. 64.36% of the stock is currently owned by institutional investors.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.